Director & Professor, Sbarro Institute, Temple University ; University of Siena
Verified email at - Homepage
Cited by
Cited by
Guidelines for the use and interpretation of assays for monitoring autophagy
DJ Klionsky, FC Abdalla, H Abeliovich, RT Abraham, A Acevedo-Arozena, ...
Autophagy 8 (4), 445-544, 2012
RB and cell cycle progression
C Giacinti, A Giordano
Oncogene 25 (38), 5220-5227, 2006
Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle
A Koff, A Giordano, D Desai, K Yamashita, JW Harper, S Elledge, ...
Science 257 (5077), 1689-1694, 1992
Cell cycle kinases as therapeutic targets for cancer
S Lapenna, A Giordano
Nature reviews Drug discovery 8 (7), 547-566, 2009
Recruitment of p300/CBP in p53-dependent signal pathways
ML Avantaggiati, V Ogryzko, K Gardner, A Giordano, AS Levine, K Kelly
Cell 89 (7), 1175-1184, 1997
From the laboratory bench to the patient's bedside: an update on clinical trials with mesenchymal stem cells
A Giordano, U Galderisi, IR Marino
Journal of cellular physiology 211 (1), 27-35, 2007
Cell cycle and apoptosis
B Pucci, M Kasten, A Giordano
Neoplasia 2 (4), 291-299, 2000
Curcumin and cancer
A Giordano, G Tommonaro
Nutrients 11 (10), 2376, 2019
Prognostic role of the cyclin-dependent kinase inhibitor p27 in non-small cell lung cancer
V Esposito, A Baldi, A De Luca, AM Groger, M Loda, GG Giordano, ...
Cancer research 57 (16), 3381-3385, 1997
Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer
TK MacLachlan, N Sang, A Giordano
Critical Reviews™ in Eukaryotic Gene Expression 5 (2), 1995
Advantages and limitations of microarray technology in human cancer
G Russo, C Zegar, A Giordano
Oncogene 22 (42), 6497-6507, 2003
Human p300 Protein Is a Coactivator for the Transcription Factor MyoD (∗)
W Yuan, G Condorelli, M Caruso, A Felsani, A Giordano
Journal of Biological Chemistry 271 (15), 9009-9013, 1996
Polypharmacy, length of hospital stay, and in-hospital mortality among elderly patients in internal medicine wards. The REPOSI study
A Nobili, G Licata, F Salerno, L Pasina, M Tettamanti, C Franchi, ...
European journal of clinical pharmacology 67, 507-519, 2011
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
N Normanno, M Di Maio, E De Maio, A De Luca, A de Matteis, A Giordano, ...
Endocrine-related cancer 12 (4), 721-747, 2005
p300 and CBP: partners for life and death
A Giordano, ML Avantaggiati
Journal of cellular physiology 181 (2), 218-230, 1999
Role of p53 in the regulation of cellular senescence
M Mijit, V Caracciolo, A Melillo, F Amicarelli, A Giordano
Biomolecules 10 (3), 420, 2020
Detection and characterization of CD133+ cancer stem cells in human solid tumours
V Tirino, V Desiderio, R d'Aquino, F De Francesco, G Pirozzi, U Galderisi, ...
PloS one 3 (10), e3469, 2008
A 60 kd cdc2-associated polypeptide complexes with the E1A proteins in adenovirus-infected cells
A Giordano, P Whyte, E Harlow, BR Franza Jr, D Beach, G Draetta
Cell 58 (5), 981-990, 1989
p300 is required for MyoD‐dependent cell cycle arrest and muscle‐specific gene transcription
PL Puri, ML Avantaggiati, C Balsano, N Sang, A Graessmann, A Giordano, ...
The EMBO journal, 1997
Cell cycle regulation and neural differentiation
U Galderisi, FP Jori, A Giordano
Oncogene 22 (33), 5208-5219, 2003
The system can't perform the operation now. Try again later.
Articles 1–20